KAT6A Syndrome: genotype-phenotype correlation in 76 patients with pathogenic KAT6A variants.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
04 2019
Historique:
received: 09 03 2018
accepted: 26 07 2018
pubmed: 25 9 2018
medline: 19 6 2019
entrez: 25 9 2018
Statut: ppublish

Résumé

Pathogenic variants in KAT6A have recently been identified as a cause of syndromic developmental delay. Within 2 years, the number of patients identified with pathogenic KAT6A variants has rapidly expanded and the full extent and variability of the clinical phenotype has not been reported. We obtained data for patients with KAT6A pathogenic variants through three sources: treating clinicians, an online family survey distributed through social media, and a literature review. We identified 52 unreported cases, bringing the total number of published cases to 76. Our results expand the genotypic spectrum of pathogenic variants to include missense and splicing mutations. We functionally validated a pathogenic splice-site variant and identified a likely hotspot location for de novo missense variants. The majority of clinical features in KAT6A syndrome have highly variable penetrance. For core features such as intellectual disability, speech delay, microcephaly, cardiac anomalies, and gastrointestinal complications, genotype- phenotype correlations show that late-truncating pathogenic variants (exons 16-17) are significantly more prevalent. We highlight novel associations, including an increased risk of gastrointestinal obstruction. Our data expand the genotypic and phenotypic spectrum for individuals with genetic pathogenic variants in KAT6A and we outline appropriate clinical management.

Identifiants

pubmed: 30245513
doi: 10.1038/s41436-018-0259-2
pii: S1098-3600(21)00958-8
pmc: PMC6634310
mid: NIHMS1040041
doi:

Substances chimiques

Protein Isoforms 0
Histone Acetyltransferases EC 2.3.1.48
KAT6A protein, human EC 2.3.1.48

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

850-860

Subventions

Organisme : Department of Health
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : U54 HD086984
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIH HHS
ID : DP5 OD024579
Pays : United States
Organisme : Wellcome Trust
ID : WT098051
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Références

Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9585-90
pubmed: 24979783
PLoS Curr. 2014 Oct 17;6:
pubmed: 25635234
J Pediatr Genet. 2017 Jun;6(2):77-83
pubmed: 28496994
Am J Hum Genet. 2017 Jan 5;100(1):91-104
pubmed: 27939640
Am J Med Genet A. 2013 Apr;161A(4):884-8
pubmed: 23436491
Am J Med Genet A. 2017 Jan;173(1):62-71
pubmed: 27615324
Hum Genome Var. 2017;4:17045
pubmed: 31754438
JAMA. 2014 Nov 12;312(18):1880-7
pubmed: 25326637
Clin Transl Allergy. 2017 Jun 22;7:19
pubmed: 28649320
Oncogene. 2007 Aug 13;26(37):5395-407
pubmed: 17694081
Am J Hum Genet. 2017 Jan 5;100(1):105-116
pubmed: 27939639
Cell Mol Life Sci. 2011 Apr;68(7):1147-56
pubmed: 21132344
Am J Med Genet A. 2016 Jul;170(7):1791-8
pubmed: 27133397
Biochim Biophys Acta. 2015 Aug;1853(8):1818-26
pubmed: 25920810
Cell Rep. 2016 Sep 20;16(12):3311-3321
pubmed: 27653692
Am J Med Genet A. 2017 Sep;173(9):2562-2565
pubmed: 28636259
Dev Cell. 2009 Nov;17(5):674-86
pubmed: 19922872
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Genome Biol. 2016 Nov 17;17(1):233
pubmed: 27855690
N Engl J Med. 2017 Jan 5;376(1):21-31
pubmed: 27959697
Nucleic Acids Res. 2017 Jan 4;45(D1):D158-D169
pubmed: 27899622
Nature. 2017 Feb 23;542(7642):433-438
pubmed: 28135719
Genes Dev. 2006 May 1;20(9):1175-86
pubmed: 16651658
Am J Hum Genet. 2015 Mar 5;96(3):507-13
pubmed: 25728777
Am J Hum Genet. 2011 Nov 11;89(5):675-81
pubmed: 22077973
Hum Mutat. 2012 Nov;33(11):1520-5
pubmed: 22715153
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Lancet. 2015 Apr 4;385(9975):1305-14
pubmed: 25529582
Am J Hum Genet. 2015 Mar 5;96(3):498-506
pubmed: 25728775
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Blood. 2009 May 14;113(20):4866-74
pubmed: 19264921
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590
Clin Genet. 2019 Feb;95(2):253-261
pubmed: 28857140

Auteurs

Joanna Kennedy (J)

Clinical Genetics, University Hospitals Bristol, Southwell St, Bristol, UK.
University of Bristol, Bristol, UK.

David Goudie (D)

Clinical Genetics, Ninewells Hospital & Medical School, Dundee, UK.

Edward Blair (E)

Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Department of Clinical Genetics, Churchill Hospital, Headington, Oxford, UK.

Kate Chandler (K)

Manchester Centre for Genomic Medicine, St. Mary's Hospital, Central Manchester Foundation NHS Trust, Manchester Academic Health Science Centre (MAHSC), Manchester, UK.

Shelagh Joss (S)

West of Scotland Genetics Service, Queen Elizabeth University Hospital, Glasgow, UK.

Victoria McKay (V)

Cheshire & Merseyside Regional Genetics Service, Liverpool Women's NHS Foundation Trust, Crown Street, Liverpool, UK.

Andrew Green (A)

Department of Clinical Genetics, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland.
School of Medicine and Medical Science, University College Dublin, Dublin, Ireland.

Ruth Armstrong (R)

East Anglian Medical Genetics Service, Addenbrooke's Hospital, Cambridge, UK.

Melissa Lees (M)

Clinical Genetics, Great Ormond Street Hospital NHS Trust, London, UK.

Benjamin Kamien (B)

Hunter Genetics, Newcastle, Australia.

Bruce Hopper (B)

Hunter Genetics, Newcastle, Australia.

Tiong Yang Tan (TY)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Australia.

Patrick Yap (P)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Australia.
Genetic Health Service New Zealand, Auckland, New Zealand.

Zornitza Stark (Z)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Australia.

Nobuhiko Okamoto (N)

Department of Medical Genetics, Osaka Medical Center, Osaka, Japan.
Research Institute for Maternal and Child Health, Osaka Medical Center, Osaka, Japan.

Noriko Miyake (N)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Naomichi Matsumoto (N)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Ellen Macnamara (E)

National Human Genome Research Institute, NIH, Bethesda, MD, USA.

Jennifer L Murphy (JL)

National Human Genome Research Institute, NIH, Bethesda, MD, USA.

Elizabeth McCormick (E)

Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Hakon Hakonarson (H)

Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Marni J Falk (MJ)

Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Dong Li (D)

Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Patrick Blackburn (P)

Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.

Eric Klee (E)

Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.

Dusica Babovic-Vuksanovic (D)

Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.

Susan Schelley (S)

Division of Medical Genetics, Department of Pediatrics, Stanford University, Stanford, CA, USA.

Louanne Hudgins (L)

Division of Medical Genetics, Department of Pediatrics, Stanford University, Stanford, CA, USA.

Sarina Kant (S)

Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Bertrand Isidor (B)

Service de Génétique Médicale, CHU Nantes, Nantes, France.

Benjamin Cogne (B)

Service de Génétique Médicale, CHU Nantes, Nantes, France.

Kimberley Bradbury (K)

Clinical Genetics Guys and St Thomas' NHS Foundation Trust, Guys Hospital, London, UK.

Mark Williams (M)

Molecular Diagnostics, Mater Group, South Brisbane, Queensland, Australia.

Chirag Patel (C)

Genetic Health Queensland, Herston, Brisbane, Queensland, Australia.

Helen Heussler (H)

Child Development Service, Lady Cilento Children's Hospital, Brisbane, Queensland, Australia.

Celia Duff-Farrier (C)

Bristol Genetics Laboratory, Southmead Hospital, Bristol, UK.

Phillis Lakeman (P)

Academic Medical Center, Department of Clinical Genetics, Amsterdam, The Netherlands.

Ingrid Scurr (I)

Clinical Genetics, University Hospitals Bristol, Southwell St, Bristol, UK.

Usha Kini (U)

Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Department of Clinical Genetics, Churchill Hospital, Headington, Oxford, UK.

Mariet Elting (M)

Klinisch Geneticus, VU Medisch centrum, Amsterdam, The Netherlands.

Margot Reijnders (M)

Radboud University Medical Center, Department of Human Genetics, Nijmegen, The Netherlands.

Janneke Schuurs-Hoeijmakers (J)

Radboud University Medical Center, Department of Human Genetics, Nijmegen, The Netherlands.

Mohamed Wafik (M)

Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Department of Clinical Genetics, Churchill Hospital, Headington, Oxford, UK.

Anne Blomhoff (A)

Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.

Claudia A L Ruivenkamp (CAL)

Klinische Genetica, Leiden University, Leiden, The Netherlands.

Esther Nibbeling (E)

Department of Genetics, University of Groningen, Groningen, The Netherlands.

Alexander J M Dingemans (AJM)

Radboud University Medical Center, Department of Human Genetics, Nijmegen, The Netherlands.

Emilie D Douine (ED)

Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.

Stanley F Nelson (SF)

Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.

Maja Hempel (M)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.

Tatjana Bierhals (T)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.

Davor Lessel (D)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.

Jessika Johannsen (J)

Department of Pediatrics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.

Valerie A Arboleda (VA)

Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. varboleda@mednet.ucla.edu.
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. varboleda@mednet.ucla.edu.

Ruth Newbury-Ecob (R)

Clinical Genetics, University Hospitals Bristol, Southwell St, Bristol, UK. Ruth.Newbury-Ecob@UHBristol.nhs.uk.
University of Bristol, Bristol, UK. Ruth.Newbury-Ecob@UHBristol.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH